AARD
Aardvark Therapeutics, Inc.
5.00$
-3.4%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -4.0% | -7.4% | +102.6% | -6.1% | -9.7% | -12.0% | -15.9% | -17.4% | |
| – | – | – | – | -5.0% | -10.3% | +108.5% | -6.3% | -10.7% | -13.4% | -16.4% | -13.8% | |
| – | – | – | – | -4.5% | -25.1% | -57.0% | -1.9% | +51.1% | +19.8% | +32.7% | +18.3% | |
| – | – | +0.0% | +764.4% | -4.6% | -10.6% | +105.3% | -6.2% | -10.9% | -12.9% | -17.1% | -19.0% | |
| – | – | -120.1% | – | +0.3% | +1.7% | -95.2% | +66.5% | +2.9% | -2.8% | +10.0% | -42.6% | |
| – | – | – | – | -1.9% | +88.6% | +21.3% | +72.5% | +4.1% | -1.8% | +10.0% | -45.0% | |
| – | – | – | – | +199.1% | +4.6% | +15.4% | +6.9% | +2.9% | +2.8% | -23.8% | +19.3% | |
| – | – | – | – | -45.6% | +245.0% | +11.2% | +97.8% | -12.1% | -53.4% | +116.8% | -53.6% | |
| – | – | – | -564.8% | – | – | – | -9.1% | -10.6% | -12.9% | -18.4% | -14.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +1.5% | 0.0% | +0.0% | +0.2% | +0.3% | +0.0% | +0.1% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.